Adam Kolom (@adamksay) 's Twitter Profile
Adam Kolom

@adamksay

Biotech entrepreneur and investor. Cofounder and CEO, Related Sciences. Cofounder, Parker Institute for Cancer Immunotherapy.

ID: 335334292

linkhttp://www.related.vc calendar_today14-07-2011 14:38:16

569 Tweet

764 Followers

2,2K Following

Adam Kolom (@adamksay) 's Twitter Profile Photo
Adam Kolom
@adamksay

2 years ago

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new